Publications by authors named "Donald Irby"

Claim this Profile
A
A Novel Two-Part Mixture Model for the Incidence and Time Course of Cytokine Release Syndrome After Elranatamab Dosing in Multiple Myeloma Patients.
Donald Irby, Jennifer Hibma, Mohamed Elmeliegy, Diane Wang, Erik Vandendries

Clin Pharmacol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Optimization of Elranatamab to Mitigate the Risk of Cytokine Release Syndrome in Patients with Multiple Myeloma.
Mohamed Elmeliegy, Andrea Viqueira, Erik Vandendries, Anne Hickman, Umberto Conte, Donald Irby

Target Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automated Poisson regression exposure-response analysis for binary outcomes with PoissonERM.
Yuchen Wang, Luke Fostvedt, Jessica Wojciechowski, Donald Irby, Timothy Nicholas

CPT Pharmacometrics Syst Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approaches to handling missing or "problematic" pharmacology data: Pharmacokinetics.
Donald J Irby, Mustafa E Ibrahim, Anees M Dauki, Mohamed A Badawi, Sílvia M Illamola

CPT Pharmacometrics Syst Pharmacol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Murine cancer cachexia models replicate elevated catabolic pembrolizumab clearance in humans.
Alyssa Marie M Castillo, Trang T Vu, Sophia G Liva, Min Chen, Zhiliang Xie, Donald J Irby

JCSM Rapid Commun· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-Pharmacodynamic Model of Neutropenia in Patients With Myeloma Receiving High-Dose Melphalan for Autologous Stem Cell Transplant.
Yu Kyoung Cho, Donald J Irby, Junan Li, Douglas W Sborov, Diane R Mould

CPT Pharmacometrics Syst Pharmacol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis